CS logo
small CS logo
Sanofi-Aventis Administrative Office

Bridgewater, New Jersey, United States
Pharmaceutical company in Bridgewater Township, New Jersey
Sanofi Building D, Corporate Dr, Bridgewater Township, NJ 08807

About Sanofi-Aventis Administrative Office


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Sanofi
201
Bausch Health Americas, Inc.
3
AstraZeneca
1
Total Rows: 3

Clinical Trials at Sanofi-Aventis Administrative Office


During the past decade, Sanofi-Aventis Administrative Office conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 8 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer
2001-04-01
2014-12-01
Completed
3,222
Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment
2001-11-01
2004-12-01
Completed
240
Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents
2002-11-01
Completed
250
The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)
2003-08-01
2011-12-01
Completed
12,537
A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy
2001-11-01
2007-01-01
Completed
83
EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization
2002-02-01
2007-02-01
Completed
4,726
Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)
2002-10-01
2006-12-01
Completed
20,506
PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)
2003-08-01
Completed

Rows per page:

1–100 of 205

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Sanofi-Aventis Administrative Office" #1 collaborator was "Bristol-Myers Squibb" with 16 trials as a collaborator, "Regeneron Pharmaceuticals" with 12 trials as a collaborator, "Cancer International Research Group (CIRG)" with 3 trials as a collaborator, "Procter and Gamble" with 3 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSanofi: 201Sanofi: 201Bausch Health Americas, Inc.: 3Bausch Health Americas, Inc.: 3AstraZeneca: 1AstraZeneca: 1

Created with Highcharts 11.1.0Top CollaboratorsBristol-Myers Squibb: 16Bristol-Myers Squibb: 16Regeneron Pharmaceuticals: 12Regeneron Pharmaceuticals: 12Cancer InternationalResearch Group (CIRG):3Cancer InternationalResearch Group (CIRG):3Procter and Gamble: 3Procter and Gamble: 3Genentech, Inc.: 1Genentech, Inc.: 1Groupe OncologieRadiotherapie Tete etCou: 1Groupe OncologieRadiotherapie Tete etCou: 1Population HealthResearch Institute: 1Population HealthResearch Institute: 1Taiho PharmaceuticalCo., Ltd.: 1Taiho PharmaceuticalCo., Ltd.: 1

Clinical Trials Conditions at Sanofi-Aventis Administrative Office


According to Clinical.Site data, the most researched conditions in "Sanofi-Aventis Administrative Office" are "Diabetes Mellitus, Type 2" (21 trials), "Atrial Fibrillation" (9 trials), "Hypercholesterolemia" (7 trials), "Sleep Initiation and Maintenance Disorders" (7 trials) and "Breast Cancer" (6 trials). Many other conditions were trialed in "Sanofi-Aventis Administrative Office" in a lesser frequency.

Clinical Trials Intervention Types at Sanofi-Aventis Administrative Office


Most popular intervention types in "Sanofi-Aventis Administrative Office" are "Drug" (199 trials), "Device" (10 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (33 trials), "placebo" (25 trials), "Metformin" (12 trials), "Docetaxel" (9 trials) and "Rimonabant" (9 trials). Other intervention names were less common.

Clinical Trials Genders at Sanofi-Aventis Administrative Office


The vast majority of trials in "Sanofi-Aventis Administrative Office" are 181 trials for "All" genders, 15 trials for "Female" genders and 9 trials for "Male" genders.

Clinical Trials Status at Sanofi-Aventis Administrative Office


Currently, there are NaN active trials in "Sanofi-Aventis Administrative Office". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 168 completed trials in Sanofi-Aventis Administrative Office, undefined suspended trials, and 36 terminated clinical trials to date.
Out of the total trials that were conducted in Sanofi-Aventis Administrative Office, 16 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 117 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 32 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 117Phase 3: 117Phase 2: 43Phase 2: 43Phase 4: 32Phase 4: 32Phase 1: 16Phase 1: 16

Created with Highcharts 11.1.0Trials StatusCompleted: 168Completed: 168Terminated: 36Terminated: 36Withdrawn: 1Withdrawn: 1